PGNewsroom



Employee Spotlight: United Way Campaign Committee Breaks Fundraising Record

Published on

A proud supporter of our community, PreventionGenetics believes in the importance of giving back. Annually we host a company United Way Campaign with the goal of raising money and awareness for Marshfield Area United Way, which supports individuals in our area most in need. PreventionGenetics began hosting its United Way Campaign over 10 years ago, and is proud to have seen continued growth with employee engagement and funds raised each year.

Explore Your Family Health History this Holiday Season

Published on

The Holidays will look different this year. While many of us won’t be gathering with our families, it is as important as ever to talk about family health history. We share a lot with our families, including our DNA. Everyone has a family history of something, whether high blood pressure, diabetes, or a rare genetic disorder.

President’s Corner - Clinical Sequence Data 

Published on

I had mixed feelings upon reading the new Genome UK Plan. On the one hand, it was satisfying and pleasing to see firmly incorporated into the plan so many of the concepts (like for example disease prevention through genetic testing) that I and others have championed for so long. On the other hand, it was disheartening to realize how far the US is behind the UK.

Updated Intellectual Disability, Epilepsy, and Autism (IDEA) Genetic Testing Panel

Published on

Intellectual disability (ID), epilepsy, and autism spectrum disorders (ASDs) are a heterogeneous group of neurodevelopmental disorders that are inherited in a multifactorial fashion. PreventionGenetics’ Intellectual Disability, Epilepsy, and Autism (IDEA) Panel is exome-based and allows for reflex to PGxome whole exome sequencing. This panel also includes exome-wide copy number variant (CNV) detection. This method allows for cost-effective identification and reporting of potentially important, large CNVs across the full exome in conjunction with any sequencing variants and/or smaller CNVs identified within the panel.